Murine cytomegalovirus downregulates interleukin-17 in mice with retrovirus-induced immunosuppression that are susceptible to experimental cytomegalovirus retinitis

• Type of Material: Article
• Authors: Emily L. Blalock, Georgia State University; Hsin Chien, Georgia State University; Richard D. Dix, Emory University
• Language: English
• Date: 2013-03-01
• Publisher: Elsevier: 12 months
• Publication Version: Author Accepted Manuscript (After Peer Review)
• Copyright Statement: © 2013 Elsevier Ltd. All rights reserved.
• License: Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.1016/j.cyto.2013.01.009
• Title of Journal or Parent Work: Cytokine
• ISSN: 1043-4666
• Volume: 61
• Issue: 3
• Start Page: 862
• End Page: 875
• Grant/Funding Information: This work has been supported in part by NIH/NEI Grant EY010568; NIH/NEI Core Grant P30EY006360; and Fight for Sight, Inc.
• Keywords: Cell Biology; PROTEINS; Science & Technology; TH17; AIDS; CD4(+) T-CELLS; Suppressor of cytokine signaling-3; AUTOIMMUNITY; INDUCTION; MACROPHAGES; Biochemistry & Molecular Biology; CYTOKINES; EXPRESSION; Interleukin-17; Life Sciences & Biomedicine; RECEPTOR; T(H)17 CELLS; Immunology; Human cytomegalovirus; Interleukin-10
• Research Categories: Biology, Microbiology; Biology, Cell; Health Sciences, Opthamology

Abstract

Interleukin-17 (IL-17), a pro-inflammatory cytokine produced by CD4+ Th17 cells, has been associated with the pathogenesis of several autoimmune diseases including uveitis. The fate of IL-17 during HIV/AIDS, however, remains unclear, and a possible role for IL-17 in the pathogenesis of AIDS-related diseases has not been investigated. Toward these ends, we performed studies using a well-established animal model of experimental murine cytomegalovirus (MCMV) retinitis that develops in C57/BL6 mice with retrovirus-induced immunosuppression (MAIDS). After establishing baseline levels for IL-17 production in whole splenic cells of healthy mice, we observed a significant increase in IL-17 mRNA levels in whole splenic cells of mice with MAIDS of 4-weeks (MAIDS-4), 8-weeks (MAIDS-8), and 10-weeks (MAIDS-10) duration. In contrast, enriched populations of splenic CD4+ T cells, splenic macrophages, and splenic neutrophils exhibited a reproducible decrease in levels of IL-17 mRNA during MAIDS progression. To explore a possible role for IL-17 during the pathogenesis of MAIDS-related MCMV retinitis, we first demonstrated constitutive IL-17 expression in retinal photoreceptor cells of uninfected eyes of healthy mice. Subsequent studies, however, revealed a significant decrease in intraocular levels of IL-17 mRNA and protein in MCMV-infected eyes of MAIDS-10 mice during retinitis development. That MCMV infection might cause a remarkable downregulation of IL-17 production was supported further by the finding that systemic MCMV infection of healthy, MAIDS-4, or MAIDS-10 mice also significantly decreased IL-17 mRNA production by splenic CD4+ T cells. Based on additional studies using IL-10 -/- mice infected systemically with MCMV and IL-10 -/- mice with MAIDS infected intraocularly with MCMV, we propose that MCMV infection downregulates IL-17 production via stimulation of suppressor of cytokine signaling (SOCS)-3 and interleukin-10.